TrialBMC nephrology2024

Impact of renal impairment on the pharmacokinetic profile of intravenous difelikefalin, a kappa opioid receptor agonist for the treatment of pruritus.

Robert H Spencer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.